SEC Form 4 · accession 0001144204-16-106816
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G Moussa
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 2, 2016 | A | 17,500 | $0.00 | A | 81,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4,F3 | $4.15 | Jun 2, 2016 | A | 8,000 | A | Jun 2, 2016 | Jun 2, 2026 | Common Stock | 8,000 | 0 | D |
Explanation of responses
- F1The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer and will vest on June 2, 2017.
- F2Upon vesting, the reporting person will receive the number of shares of the issuer's common stock equal to the number of restricted stock units previously granted, without the payment of further consideration.
- F3The options, granted in consideration for the reporting person's past services to the issuer, vested on the date of grant.
- F4The options were originally granted in consideration of the reporting person's past services to the issuer and without payment of cash consideration.